| PRSS16 expression profile based on | ||||||||||||||||||||
ACC : Adrenocortical carcinomaNote
Cancer stage information is not available for 2 samples.
| ||||||||||||||||||||
ACC : Adrenocortical carcinomaNote
Patient race information is not available for 11 samples.
| ||||||||||||||||||||
ACC : Adrenocortical carcinoma
| ||||||||||||||||||||
ACC : Adrenocortical carcinomaNote
Three samples belonging to patients aged below 20 are not considered in the above plot.
| ||||||||||||||||||||
ACC : Adrenocortical carcinomaNote
Nodal metastais status is not available for 2 samples.
| ||||||||||||||||||||
ACC : Adrenocortical carcinomaTP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data.
| ||||||||||||||||||||